Who has invested in ORIC Pharmaceuticals?

The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company are named among the investors backing ORIC Pharmaceuticals.

ORIC Pharmaceuticals Funding: $900M Raised, IPO (2020)

ORIC Pharmaceuticals funding overview

ORIC Pharmaceuticals is a Biotech company based in South San Francisco. ORIC Pharmaceuticals has raised $900M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2020. The round record for ORIC Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company. 5 distinct backers are named across the disclosed rounds.

ORIC Pharmaceuticals at a glance

Total raised: $900M
Latest round: IPO
Latest round date: April 2020
Industry: Biotech
Headquarters: South San Francisco
Notable investors: The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company

Frequently asked about ORIC Pharmaceuticals funding

How much has ORIC Pharmaceuticals raised?: ORIC Pharmaceuticals has raised $900M in total disclosed funding across the rounds on record.
Who has invested in ORIC Pharmaceuticals?: The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company are named among the investors backing ORIC Pharmaceuticals.
What was the latest ORIC Pharmaceuticals funding round?: The most recent disclosed round is an IPO, announced in April 2020.
Where is ORIC Pharmaceuticals based?: ORIC Pharmaceuticals is based in South San Francisco.
What sector does ORIC Pharmaceuticals operate in?: ORIC Pharmaceuticals is tracked under Biotech from South San Francisco, with $900M in disclosed funding.
When did ORIC Pharmaceuticals last raise?: The last disclosed ORIC Pharmaceuticals round closed in April 2020 at IPO.

Round data for ORIC Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in South San Francisco and backer lists below.

ORIC Pharmaceuticals Funding: $900M Raised, IPO (2020)

ORIC Pharmaceuticals funding overview

ORIC Pharmaceuticals at a glance

Frequently asked about ORIC Pharmaceuticals funding

ORIC Pharmaceuticals founders (1)

Companies related to ORIC Pharmaceuticals (40)

Browse related funding lists (6)